Laura J Owen1, Frederick C Wu2, Rahel M Büttler3, Brian G Keevil4. 1. Manchester Academic Health Science Centre, Biochemistry Department, University Hospital of South Manchester, Manchester, UK laura.owen@uhsm.nhs.uk. 2. Andrology Research Unit, The University of Manchester, Manchester, UK. 3. Endocrine Laboratory, Department of Clinical Chemistry, VU University Medical Center Amsterdam, Amsterdam, The Netherlands. 4. Manchester Academic Health Science Centre, Biochemistry Department, University Hospital of South Manchester, Manchester, UK.
Abstract
BACKGROUND: The measurement of androgens in many laboratories is often limited to testosterone. To more accurately determine the androgen status in both sexes, the measurement of other androgens such as dihydrotestosterone, the more potent metabolite of testosterone, and androstenendione and dehydroepiandrosterone, the most abundant circulating androgens in women would be informative. We report a combined liquid chromatography tandem mass spectrometry method for the measurement of these androgens. METHODS: Internal standards in methanol (10 µL) were added to 100 µL serum followed by the addition of zinc sulphate (100 µL). After mixing, 100 µL of acetonitrile was added and was further mixed. The samples were centrifuged and the steroids extracted using an automated online solid phase extraction on a C18 cartridge by a Waters Acquity with online sample manager coupled to a TQS mass spectrometer. RESULTS: Separation of the androgens was achieved by liquid chromatography. The run time was 6.5 min per sample. The lower limit of quantitation was 0.1 nmol/L for testosterone, androstenedione and dihydrotestosterone and 1 nmol/L for dehydroepiandrosterone. The coefficient of variation of the assay in serum for testosterone was <6%, androstenedione <8% and dihydrotestosterone and dehydroepiandrosterone <10%. DISCUSSION: We have developed a rapid assay for the liquid chromatography tandem mass spectrometry measurement of testosterone, androstenedione, dihydrotestosterone and dehydroepiandrosterone in a routine clinical laboratory. The assay requires a small volume of serum, and all analytes are measured simultaneously. The assay is rapid and simple to execute offering the potential for routine clinical application.
BACKGROUND: The measurement of androgens in many laboratories is often limited to testosterone. To more accurately determine the androgen status in both sexes, the measurement of other androgens such as dihydrotestosterone, the more potent metabolite of testosterone, and androstenendione and dehydroepiandrosterone, the most abundant circulating androgens in women would be informative. We report a combined liquid chromatography tandem mass spectrometry method for the measurement of these androgens. METHODS: Internal standards in methanol (10 µL) were added to 100 µL serum followed by the addition of zinc sulphate (100 µL). After mixing, 100 µL of acetonitrile was added and was further mixed. The samples were centrifuged and the steroids extracted using an automated online solid phase extraction on a C18 cartridge by a Waters Acquity with online sample manager coupled to a TQS mass spectrometer. RESULTS: Separation of the androgens was achieved by liquid chromatography. The run time was 6.5 min per sample. The lower limit of quantitation was 0.1 nmol/L for testosterone, androstenedione and dihydrotestosterone and 1 nmol/L for dehydroepiandrosterone. The coefficient of variation of the assay in serum for testosterone was <6%, androstenedione <8% and dihydrotestosterone and dehydroepiandrosterone <10%. DISCUSSION: We have developed a rapid assay for the liquid chromatography tandem mass spectrometry measurement of testosterone, androstenedione, dihydrotestosterone and dehydroepiandrosterone in a routine clinical laboratory. The assay requires a small volume of serum, and all analytes are measured simultaneously. The assay is rapid and simple to execute offering the potential for routine clinical application.
Authors: L Roli; D Santi; S Belli; S Tagliavini; S Cavalieri; M C De Santis; E Baraldi; F Fanelli; M Mezzullo; A R Granata; U Pagotto; R Pasquali; V Rochira; C Carani; M Simoni; T Trenti Journal: J Endocrinol Invest Date: 2017-03-21 Impact factor: 4.256
Authors: Rosemary Basson; Julia I O'Loughlin; Joanne Weinberg; Allan H Young; Tamara Bodnar; Lori A Brotto Journal: Psychoneuroendocrinology Date: 2019-03-08 Impact factor: 4.905
Authors: Lisa Lindheim; Mina Bashir; Julia Münzker; Christian Trummer; Verena Zachhuber; Bettina Leber; Angela Horvath; Thomas R Pieber; Gregor Gorkiewicz; Vanessa Stadlbauer; Barbara Obermayer-Pietsch Journal: PLoS One Date: 2017-01-03 Impact factor: 3.240
Authors: Li-Wei Cho; Thozhukat Sathyapalan; Eric S Kilpatrick; Brian G Keevil; Adrian G Miller; Anne M Coady; Lina Ahmed; Stephen L Atkin Journal: BMC Endocr Disord Date: 2017-05-19 Impact factor: 2.763
Authors: Lisa Lindheim; Mina Bashir; Julia Münzker; Christian Trummer; Verena Zachhuber; Thomas R Pieber; Gregor Gorkiewicz; Barbara Obermayer-Pietsch Journal: Front Microbiol Date: 2016-08-25 Impact factor: 5.640